Accounting for Contingencies: Disclosure of Future Business Risks

Jonathan B. Schiff, Allen Schiff, Hannah Rozen

Management accounting quarterly · 2012 · 10 citations · 0 references

Concepts

Abstract

At 12 months, bimonthly and T&E ranibizumab were noninferior to PRN in naïve nAMD.